At Evotec SE, we believe Quality is far more than compliance. It is a strategic differentiator, a driver of client trust, and a critical enabler of scientific and operational excellence.
We are seeking an exceptional executive leader to join our Global Operations Leadership Team as EVP, Global Head of Quality. This is a highly strategic enterprise role with responsibility across our global Drug Discovery and Drug Development network spanning Europe and the USA.
Reporting directly to the Chief Operations Officer, you will lead the transformation of Quality into a modern, commercially impactful, globally harmonized function that supports Evotec’s next phase of growth under Project Horizon.
This role is designed for a leader who understands the realities of complex life science environments, can navigate global matrix organisations, and knows how to turn quality excellence into a competitive advantage.
Define and drive Evotec’s global Quality strategy across Drug Discovery and Drug Development
Lead large-scale transformation initiatives across systems, structures, processes, and capabilities
Position Quality as a visible differentiator in client partnerships, business development, and strategic growth
Build strong executive relationships internally and externally across pharma, biotech, and regulatory bodies
Ensure world-class GXP compliance while enabling agility, scalability, and operational performance
Lead and inspire an international Quality organisation across the UK, Germany, France, Italy, and the USA
This is an opportunity to shape how Quality contributes to business performance, client confidence, innovation, and long-term enterprise value.
Significant senior leadership experience within a CRO, biotech, or pharma.
Strong understanding of partner expectations and unmet needs in complex CRO settings
Proven track record leading transformation in global, matrixed, multi-site organisations
Deep expertise across GXP environments including GLP, GCP, and GMP
Strong commercial acumen and experience positioning Quality as a business enabler and strategic differentiator
Exceptional stakeholder management and influencing capability at executive level
Experience leading large international teams through change, complexity, and growth
The ability to combine scientific credibility, operational rigor, and business pragmatism
Evotec is a global biotechnology company operating at the forefront of drug discovery and development. With more than 4,000 scientific experts across Europe and the USA, we partner with leading pharmaceutical, biotech, and academic organisations to accelerate the development of medicines that matter.
As part of our transformation journey under Project Horizon, we are evolving our operating model to drive sustainable growth, strengthen execution, and further differentiate our scientific and operational capabilities globally.
This role offers the opportunity to influence that transformation at enterprise scale. Regular international travel across Evotec sites is expected.
We look forward to hearing from leaders who are ready to redefine what Quality can deliver in a modern, science-driven environment.
FR : Dans le cadre de sa politique Diversité, Evotec étudie, à compétences égales, toutes les candidatures dont celles des personnes en situation de handicap.
ENG : In the frame of our Diversity policy, Evotec considers, with equal competences, all applications including people with disabilities.
Evotec is a biotechnology company that is committed to advancing drug discovery and development. Through flexible business models, we collaborate with pharmaceutical companies, biotechs, foundations, and government agencies on a substantial scale. We believe that by working together, we can make a difference in the lives of patients.
Our Pipeline Co-Creation model represents our adaptable, multi-modality, fully integrated end-to-end approach to drive collaborations and services across all phases of drug discovery and development – from discovery of novel targets to achieving Proof of Concept in the clinic and into commercial manufacturing.
We aspire to contribute data-driven disease understanding and early disease relevance in humans to bring the probability of success up. We select the right modality, which is then propelled forward on our platforms by our passionate people striving for the fastest and most effective ways towards patient impact. This is enabled by convergence of human ingenuity with data and AI.
We also offer specific solutions, products, and CRO/CDMO-like services, always in support of the Biopharma R&D innovator. Our more than 4,000 scientists work closely with numerous partners concurrently, delivering fully integrated research and development portfolios or individual projects with the highest quality standards and efficiency, coupled with great science, passion, engagement, and communication.
